







Making a difference for traumatic brain injury patients
Emerging new Company veriNOS pharmaceuticals, established in…
14 March 2023/by Marketing Team
Sector Moves: February 2023
February moves 2023
Investment Firms
Patient Square…
2 March 2023/by optimusInvestment Firms
Patient Square…
Raising awareness of Rare Disease
Each year, Rare Disease Day aims to raise awareness of rare diseases…
28 February 2023/by Marketing TeamChanging the way we see CAR-T – Building out, not down
Co-founder and Chief Scientific Officer at Leucid Bio, Dr…
21 February 2023/by LRuasLook after your heart month 2023
The sad death at the young age of 54 of David Jolicoeur,…
16 February 2023/by LRuasOptimum’s Women & Girls in Science Campaign 2023
On the International Day of Women and Girls in Science,…
8 February 2023/by LRuasOptimum’s clients are at the forefront of Cancer research
World Cancer Day is a moment when all of us stop…
Scrip Asks… What does 2023 hold for Biopharma?
More than one hundred industry executives and experts provided…
31 January 2023/by LRuasJane Osbourn Presented with Lifetime Achievement Award by BIA
Optimum Strategic Communications sends our heartfelt congratulations…
27 January 2023/by LRuas
The ‘must-attend’ Healthcare conferences of Q1 & Q2 2023
… And just like that it’s ANOTHER new year! If you are still…
13 January 2023/by LRuas
Evaluate Vantage shares biopharma predictions for 2023
In this report, Amy Brown, Edwin Elmhirst and Joanne Fagg of…
6 January 2023/by LRuas2022 | Optimum’s Year in Review
It’s nearly the end of 2022! It was an exciting year for Optimum’s…
15 December 2022/by LRuasInsights
We’d love to hear from you
For more information about Optimum Strategic Communications, please get in touch.
We are specialists with an indepth understanding of how to communicate complex science to investors and corporate stakeholders. We help companies on their journey as they grow and have been trusted by hundreds of clients from around the world, both public and private, large and small.
Locations
- London
- Amsterdam
- Stockholm
- Zurich
- New York
Professor Melief of ISA Pharmaceuticals awarded 2 prestigious awards at the 37th Society for Immunotherapy of Cancer Annual Meeting
/in InsightsLSX and Jefferies – Insights from the busiest week in European biotech
/in Insights, Optimum newsPanel Summaries from Optimum’s 14th Annual Healthcare Investor Conference 2022
/in Insights, Optimum newsDan Mahony & Gareth Powell – Global healthcare investing: Can hindsight hone the crystal ball for the future? A fireside chat moderated by Amy Brown, Evaluate Vantage
/in Insights, Optimum newsFinancing growth: Walking the tightrope – Annual Healthcare Investor Conference Insight
/in Insights, Optimum newsCan private markets continue to drive development in Life Sciences? – Insights from Optimum’s Healthcare Conference
/in Insights, Optimum news